These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2006-005127-42 Effect of Prandial Treatment with Insulin Glulisine compared to Regular Human Insulin on Postprandial Endothelial Function and Microvascular Stress in Type 2 Diabetic Patients 2007-03-01 due-trials
Not reported 2007-002060-10 Pharmacokinetics and Pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen® insulin pen compared to inhaled insulin administered with the Exubera® device 2007-11-01 due-trials
Not reported 2007-006109-26 Impact of Insulin Glargine compared to Insulin Detemir in combination with Metformin (BOT) on prandial beta cell function and overall metabolic control in type 2 diabetic patients with insufficient me... 2009-03-17 due-trials
Not reported 2009-015993-37 Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients – Investigation on Postprandial Excursions of Proinsulin and PAI-1 Levels 2010-07-19 due-trials
Not reported 2009-016745-25 Investigation of a switch from Insulin Therapy to a metformin & saxagliptin combination in patients with type 2 diabetes mellitus 2011-03-11 due-trials
Not reported 2010-018619-14 Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus 2010-11-05 due-trials
Not reported 2010-023509-37 A prospective, randomized, single-blind, placebo-controlled, two-armed, phase IV study in patients with subclinical hypothyroidism treated over 52 weeks either with levothyroxine in adjusted dosing to... 2013-08-09 due-trials
Not reported 2011-003733-34 Human Insulin Analogs: Evaluation of inflammatory mRNA expression of Macrophages and Endothelial function of Short-acting insulin – HERMES Pilot Study 2012-05-25 due-trials
Not reported 2011-004286-32 Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients with moderate Metabolic Control during Metformin Monotherapy 2012-08-07 due-trials
Not reported 2011-005806-32 Clinical Study to Collect Clinical Data Sets for 2012-05-16 due-trials
Not reported 2012-000179-17 Effect of Linagliptin in comparison with Glimepiride as add on to Metformin on postprandial beta cell function, postprandial metabolism and oxidative stress in patients with type 2 diabetes mellitus 2012-09-25 due-trials